The emerging approach of the medication represents a exciting advance in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide982503.blogaritma.com/39840979/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment